Saliva electrolyte analysis and xerostomia-related quality of life in nasopharyngeal carcinoma patients following intensity-modulated radiation therapy

Nasopharyngeal carcinoma (NPC), also known as the “Canton tumor”, is one of the most common cancers in southern China. In Hong Kong, the Hong Kong Cancer Registry has noted that NPC was the 6th most common cancer in males with 599 new cases and an incidence rate of 17.7 in 100,000 in 2016. The mortality of NPC ranked 8th in male and 10th in bot h sexes [1]. The first-line treatment for nasopharyngeal cancer is radiation therapy. Xerostomia is a common, debilitating complication of radiation therapy for nasopharyngeal carcinoma [2].
Source: Radiotherapy and Oncology - Category: Radiology Authors: Tags: Original Article Source Type: research